Vladimir Rafalskiy

Risankizumab for Ulcerative Colitis

Edouard Louis, Stefan Schreiber, Remo Panaccione et al. · JAMA · 2024 · 110 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

1425 SIMEPREVIR (TMC435) WITH PEGINTERFERON/RIBAVIRIN FOR CHRONIC HCV GENOTYPE-1 INFECTION IN TREATMENT-NAÏVE PATIENTS: RESULTS FROM QUEST-1, A PHASE III TRIAL

Ira M. Jacobson, G.J. Dore, Graham R. Foster et al. · Journal of Hepatology · 2013 · 90 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Distribution and antibiotic resistance profile of key Gram-negative bacteria that cause community-onset urinary tract infections in the Russian Federation: RESOURCE multicentre surveillance 2017 study

Vladimir Rafalskiy, S. V. Yakovlev, O. I. Epstein et al. · Journal of Global Antimicrobial Resistance · 2019 · 41 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Assessing routine healthcare pattern for type 2 diabetes mellitus in Russia: the results of рharmacoepidemiological study (FORSIGHT-DM2)

D. Yu. Belousov, Vladimir Rafalskiy, V. Y. Kalashnikov et al. · Diabetes Mellitus · 2016 · 29 citations · Full text

Medicine, Endocrinology, Internal Medicine +17

Surface-enhanced Raman spectroscopy for antiplatelet therapy effectiveness assessment

Andrey Zyubin, Vladimir Rafalskiy, Anna V. Tcibulnikova et al. · Laser Physics Letters · 2020 · 26 citations · Full text

Natural Sciences, Materials Science, Pharmacology +14